𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Raynaud's phenomenon and scleroderma dysregulated neuroendothelial control of vascular tone

✍ Scribed by Bashar Kahaleh; Marco Matucci Cerinic

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
388 KB
Volume
38
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevention of vascular damage in sclerod
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril
✍ A. E. Gliddon; C. J. DorΓ©; C. M. Black; N. McHugh; R. Moots; C. P. Denton; A. He πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the efficacy and tolerability of prolonged administration of quinapril, a long‐acting angiotensin‐converting enzyme inhibitor, in the management of the peripheral vascular manifestations of limited cutaneous systemic sclerosis (lcSSc) and in the prevention of t

Increased asymmetric dimethylarginine an
Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: Implications for vascular dysfunction and progression of disease
✍ Sanjay Rajagopalan; Dana Pfenninger; Christine Kehrer; Anjan Chakrabarti; Emily πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 1 views

## Abstract ## Objective To compare microvascular and macrovascular functions in a cohort of patients with primary and secondary Raynaud's phenomenon (RP) who were matched for demographic, risk factor, and severity profiles. ## Methods Forty patients with primary or secondary RP matched for vasc